Opus Genetics (IRD) Tax Provisions (2022 - 2025)

Opus Genetics (IRD) has reported Tax Provisions for 3 consecutive years, with -$10.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Tax Provisions changed N/A year-over-year to -$10.4 million; the TTM figure through Mar 2026 stood at -$10.4 million (changed N/A YoY), while the FY2025 annual figure was -$10.4 million, changed N/A from the prior year.
• Tax Provisions retreated to -$10.4 million in Q4 2025 per IRD's latest filing, from -$2000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $315000.0 in Q4 2022 and bottomed at -$10.4 million in Q4 2025.
• Historically, Tax Provisions has averaged -$2.5 million across 3 years, with a median of $6000.0 in 2023.
• On a YoY basis, Tax Provisions climbed as much as 100.63% in 2023 and fell as far as 100.63% in 2023.
• Opus Genetics' Tax Provisions stood at $315000.0 in 2022, then slumped by 100.63% to -$2000.0 in 2023, then tumbled by 520600.0% to -$10.4 million in 2025.
• Business Quant data shows IRD's Tax Provisions at -$10.4 million in Q4 2025, -$2000.0 in Q4 2023, and $14000.0 in Q3 2023.